Search results for "Hydroxyethyl starch"

showing 9 items of 29 documents

Pharmacokinetics and pharmacodynamics of hydroxyethyl starch in hypovolemic pigs; a comparison of peripheral and intraosseous infusion.

1999

Intraosseous (i.o.) infusion is considered a useful technique for the administration of medications and fluids in emergency situations when peripheral intravascular access is not possible. This study investigated the effectiveness of i.o. versus intravenous (i.v.) infusion of hydroxyethyl starch (HES 200/0.5) in hypovolemic pigs. Twenty-three pigs (8- to 9-week-old) were anaesthesized, instrumented and blood was withdrawn (25-30 ml/kg) to50 mmHg mean arterial pressure (MAP). The animals were left untreated in haemorrhage for 30 min. Relevant haemodynamic parameters were monitored and blood samples were collected for blood gas and HES concentration analysis. Infusion of HES via i.v. or i.o. …

business.industrySwineResuscitationPlasma SubstitutesShockEmergency NursingHydroxyethyl starchInfusions IntraosseousPeripheralHydroxyethyl Starch DerivativesRoute of administrationIntraosseous infusionPharmacokineticsIntensive careShock (circulatory)AnesthesiaHypovolemiaEmergency MedicineMedicineAnimalsmedicine.symptomCardiology and Cardiovascular MedicinebusinessInfusions Intravenousmedicine.drugResuscitation
researchProduct

Carbohydrate-Based Nanocarriers Exhibiting Specific Cell Targeting with Minimum Influence from the Protein Corona.

2015

Whenever nanoparticles encounter biological fluids like blood, proteins adsorb on their surface and form a so-called protein corona. Although its importance is widely accepted, information on the influence of surface functionalization of nanocarriers on the protein corona is still sparse, especially concerning how the functionalization of PEGylated nanocarriers with targeting agents will affect protein corona formation and how the protein corona may in turn influence the targeting effect. Herein, hydroxyethyl starch nanocarriers (HES-NCs) were prepared, PEGylated, and modified on the outer PEG layer with mannose to target dendritic cells (DCs). Their interaction with human plasma was then s…

endocrine systemDrug CarriersChemistryNanoparticleMannoseProtein CoronaGeneral ChemistryDendritic CellsCatalysisPolyethylene GlycolsHydroxyethyl Starch Derivativeschemistry.chemical_compoundDrug Delivery SystemsBiochemistryDrug deliveryPEG ratioBiophysicsSurface modificationHumansNanoparticlesProtein CoronaNanocarriersMannoseProtein adsorptionAngewandte Chemie (International ed. in English)
researchProduct

Haemoconcentration by gelatin-induced acceleration of erythrocyte sedimentation rate

2000

Erythrocyte sedimentation rates from 40 suspensions of packed red blood cells in modified fluid gelatin, 4% albumin solution, 6% hydroxyethyl starch and normal saline were measured at room temperature using Westergren's method. The erythrocyte sedimentation rate was extremely high in gelatin and this increase was significant after 10-60 min when compared with the other fluids. Erythrocyte sedimentation rates in albumin, hydroxyethyl starch and normal saline were low and there were no differences between these fluids [erythrocyte sedimentation after 60 min, median (interquartile range): gelatin 128 (111.2-130.0) mm, albumin 2 (1.5-2.0) mm, hydroxyethyl starch 1.5 (1.0-1.6) mm, normal saline …

medicine.medical_specialtyChromatographyfood.ingredientmedicine.diagnostic_testbusiness.industrymedicine.medical_treatmentAlbuminHydroxyethyl starchGelatinErythrocyte aggregationSurgeryRed blood cellAnesthesiology and Pain Medicinemedicine.anatomical_structurefoodErythrocyte sedimentation ratemedicinePacked red blood cellsbusinessSalinemedicine.drugAnaesthesia
researchProduct

Nanocapsules generated out of a polymeric dexamethasone shell suppress the inflammatory response of liver macrophages.

2012

Abstract Dexamethasone (DXM) is a synthetic glucocorticoid with anti-inflammatory properties. Targeted delivery of dexamethasone to inflammatory cells, e.g. macrophages and Kupffer cells represents a promising approach to minimize side effects. The aim of the present study was to induce a targeted transport of novel DXM-based biodegradable nanocapsules to phagocytic cells. Nanocapsules (NCs) consisting of a hydroxyethylated glucose polymer (hydroxyethyl starch, HES) shell with encapsulated DXM and NCs synthesized exclusively in inverse miniemulsion out of DXM were investigated. Non-parenchymal murine liver cells served as target cells. HES-DXM NCs were predominantly incorporated by Kupffer …

medicine.medical_specialtyMaterials sciencemedicine.drug_classKupffer CellsInflammatory responseBiomedical EngineeringAnti-Inflammatory AgentsPharmaceutical ScienceMedicine (miscellaneous)BioengineeringStimulationHydroxyethyl starchPharmacologybehavioral disciplines and activitiesNanocapsulesDexamethasoneProinflammatory cytokineHydroxyethyl Starch DerivativesMiceDrug Delivery SystemsNanocapsulesInternal medicinemental disordersmedicineAnimalsGeneral Materials ScienceDexamethasoneCells CulturedMice Inbred C57BLEndocrinologyMolecular MedicineCorticosteroidCytokinesFemaleGlucocorticoidmedicine.drugNanomedicine : nanotechnology, biology, and medicine
researchProduct

Pruritus precipitated by hydroxyethyl starch: a review.

2005

Summary Hydroxyethyl starch (HES) is widely used for fluid management in broad populations of patients, particularly in the surgery and intensive care settings. Pruritus, often manifested as pruritic crises, is increasingly being recognized as a common major adverse effect of HES administration. This iatrogenic form of pruritus is frequently severe and protracted with a serious negative impact on patient quality of life, including sleep disturbance, disruption of daily routine and mental distress. Such pruritus is generally refractory to available therapies and can persist for up to 12–24 months. All currently clinically available HES solutions entail the risk of pruritus, including those o…

medicine.medical_specialtyPlasma SubstitutesDermatologyFluid managementHydroxyethyl starchHydroxyethyl Starch DerivativesQuality of lifeIntensive careMedicineHumansTissue Distributionskin and connective tissue diseasesIntensive care medicineAdverse effectreproductive and urinary physiologyDaily routineHetastarchSleep disorderintegumentary systemDose-Response Relationship Drugbusiness.industryPruritusmedicine.diseaseSurgeryDrug Eruptionsbiological phenomena cell phenomena and immunitybusinessmedicine.drugThe British journal of dermatology
researchProduct

Evaluation of early and late histamine release by three standard volume substitutes

2001

Following meta-analysis [1], the use of colloidal solutions in intensive care medicine is under discussion. Although polygeline [2] and human albumin are known to cause histamine release, other substances eg hydroxyethyl starch were thought to be without effect. Histamine release depends on the clinical scenario, concomitant drugs, infusion speed, duration and amount of infusion. However, there is no information about their effect regarding time periods longer than immediate reactions. This study investigated the histamine releasing effects of three plasma substitutes administered and observed over a longer period of time, simulating many of the clinical scenarios.

medicine.medical_specialtybusiness.industryHuman albuminPharmacologyHydroxyethyl starchCritical Care and Intensive Care MedicinePlasma Substituteschemistry.chemical_compoundchemistryConcomitantPolygelineEmergency medicineMeeting AbstractmedicinebusinessClinical scenarioHistaminemedicine.drugCritical Care
researchProduct

Protective effects of plasma replacement fluids on erythrocytes exposed to mechanical stress

2000

Haemoglobin release from 40 suspensions of packed red blood cells in modified fluid gelatin, 4% albumin solution, 6% hydroxyethyl starch and normal saline was investigated in vitro during circulation with a roller pump from a heart-lung machine for 120 min at a flow rate of 2.5 l.min-1 at room temperature. The lowest haemoglobin release was obtained with erythrocytes in modified fluid gelatin, whereas free haemoglobin concentrations became progressively higher with albumin, hydroxyethyl starch and normal saline [median free haemoglobin (interquartile range) after 120 min circulation: gelatin 493 (360-601) mg.l-1, albumin 692 (590-1111) mg.l-1, hydroxyethyl starch 1121 (692-1518) mg.l-1, nor…

medicine.medical_specialtyfood.ingredientChromatographybusiness.industrymedicine.medical_treatmentExtracorporeal circulationAlbuminHydroxyethyl starchmedicine.diseaseHaemolysisGelatinHemolysisSurgeryRed blood cellAnesthesiology and Pain Medicinefoodmedicine.anatomical_structureMedicinebusinessSalinemedicine.drugAnaesthesia
researchProduct

Steroid and vasoactive treatment for acute deafness after attempted hearing preservation acoustic neuroma surgery.

2004

<i>Objective:</i> To investigate whether intravenous steroid and vasoactive therapy in the acute postoperative period improves hearing outcome in patients who develop acute deafness after attempted hearing preservation surgery for acoustic neuroma (AN) through a retrosigmoid or a middle cranial fossa approach. <i>Study Design and Setting:</i> Retrospective controlled study in a tertiary care center. Thirty-six patients who had developed acute deafness after hearing preservation surgery for treatment of an AN were reviewed. Preoperative AAOHNS hearing class was A in 2, B in 2 and D in 32 patients. Twenty-seven patients were treated with prednisolone, hydroxyethyl star…

medicine.medical_specialtymedicine.drug_classHearing lossmedicine.medical_treatmentPrednisoloneVasodilator AgentsAnti-Inflammatory AgentsAcoustic neuromaDeafnessHydroxyethyl Starch DerivativesPostoperative ComplicationsAcoustic neuroma surgeryVasoactiveotorhinolaryngologic diseasesmedicineEvoked Potentials Auditory Brain StemHumansIn patientPentoxifyllineRetrospective StudiesSalvage TherapyHearing preservationChemotherapybusiness.industryNeuroma Acousticmedicine.diseaseSurgeryOtorhinolaryngologyAnesthesiaAcute DiseaseInjections IntravenousCorticosteroidDrug Therapy Combinationmedicine.symptombusinessORL; journal for oto-rhino-laryngology and its related specialties
researchProduct

Monophosphoryl lipid A coating of hydroxyethyl starch nanocapsules drastically increases uptake and maturation by dendritic cells while minimizing th…

2015

Enhancing delivery of antigens to dendritic cells (DCs) is essential for the induction of vigorous antigen-specific cellular immune responses. Aim of the present study was to evaluate the properties of hydroxyethyl starch nanocapsules (HES-NCs) functionalized with anti-CD40, anti-DEC205, interferon-γ (IFNγ) and/or monophosphoryl lipid A (MPLA) with respect to the overall uptake, the released cytokine profile, and the influence on phenotypic maturation of human monocyte-derived DCs using flow cytometry, confocal microscopy and enzyme-linked immunosorbent assays. NC uptake by DCs was significantly enhanced by functionalizing NCs with anti-CD40 or MPLA. With respect to the cytokine profile and…

medicine.medical_treatmentMonophosphoryl Lipid ANanocapsulesFlow cytometryHydroxyethyl Starch DerivativesImmune systemAntigenAdjuvants ImmunologicNanocapsulesInterferonmedicineHumansCells CulturedMicroscopy ConfocalGeneral VeterinaryGeneral Immunology and Microbiologymedicine.diagnostic_testChemistryPublic Health Environmental and Occupational HealthDendritic CellsTh1 CellsInterleukin-12Cell biologyToll-Like Receptor 4Infectious DiseasesLipid ANanomedicineBiochemistryMolecular MedicineAdjuvantCD80medicine.drugVaccine
researchProduct